Filing Details
- Accession Number:
- 0001179110-18-011567
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-09-19 18:26:06
- Reporting Period:
- 2018-09-17
- Accepted Time:
- 2018-09-19 18:26:06
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1034842 | Rigel Pharmaceuticals Inc | RIGL | Pharmaceutical Preparations (2834) | 943248524 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1419579 | Anne-Marie Duliege | Rigel Pharmaceuticals, Inc. 1180 Veterans Boulevard South San Francisco CA 94080 | Evp & Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-09-17 | 115,500 | $2.54 | 115,500 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-09-17 | 115,500 | $3.50 | 0 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2018-09-17 | 37,500 | $2.11 | 37,500 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-09-17 | 37,500 | $3.50 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employe Stock Option (right to buy) | Disposition | 2018-09-17 | 115,500 | $0.00 | 115,500 | $2.54 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2018-09-17 | 37,500 | $0.00 | 37,500 | $2.11 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 268,000 | 2026-05-05 | No | 4 | M | Direct | |
| 112,500 | 2027-02-02 | No | 4 | M | Direct |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 26, 2018.
- One fourth (1/4th) of the option vests one (1) year from March 7, 2016 and thereafter the balance of the option vests in equal monthly installments over the next thirty-six (36) months.
- The shares vest over four (4) years from January 1, 2017.
Billionaire Hedge Funds
